The TUDCA trial - innovative trial designs for amyotrophic lateral sclerosis drugs?

被引：5
作者：
Ludolph, A. C. [1 ]
机构：
[1] Univ Ulm, D-89069 Ulm, Germany
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2016年 / 23卷 / 01期
关键词：
DEXPRAMIPEXOLE;
D O I：
10.1111/ene.12691
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：11 / 12
页数：2
相关论文
共 7 条
  • [1] The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis
    Cudkowicz, Merit
    Bozik, Michael E.
    Ingersoll, Evan W.
    Miller, Robert
    Mitsumoto, Hiroshi
    Shefner, Jeremy
    Moore, Dan H.
    Schoenfeld, David
    Mather, James L.
    Archibald, Donald
    Sullivan, Mary
    Amburgey, Craig
    Moritz, Juliet
    Gribkoff, Valentin K.
    [J]. NATURE MEDICINE, 2011, 17 (12) : 1652 - U169
  • [2] Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial
    Cudkowicz, Merit E.
    van den Berg, Leonard H.
    Shefner, Jeremy M.
    Mitsumoto, Hiroshi
    Mora, Jesus S.
    Ludolph, Albert
    Hardiman, Orla
    Bozik, Michael E.
    Ingersoll, Evan W.
    Archibald, Donald
    Meyers, Adam L.
    Dong, Yingwen
    Farwell, Wildon R.
    Kerr, Douglas A.
    [J]. LANCET NEUROLOGY, 2013, 12 (11) : 1059 - 1067
  • [3] Targeted antioxidative and neuroprotective properties of the dopamine agonist pramipexole and its nondopaminergic enantiomer SND919CL2x [(+)2-amino-4,5,6,7-tetrahydro-6-L-propylamino-benzathiazole dihydrochloride]
    Danzeisen, R
    Schwalenstoecker, B
    Gillardon, F
    Buerger, E
    Krzykalla, V
    Klinder, K
    Schild, L
    Hengerer, B
    Ludolph, AC
    Dorner-Ciossek, C
    Kussmaul, L
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (01) : 189 - 199
  • [4] Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis
    Elia, A. E.
    Lalli, S.
    Monsurro, M. R.
    Sagnelli, A.
    Taiello, A. C.
    Reggiori, B.
    La Bella, V.
    Tedeschi, G.
    Albanese, A.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 (01) : 45 - 52
  • [5] Dose-ranging study of riluzole in amyotrophic lateral sclerosis
    Lacomblez, L
    Bensimon, G
    Leigh, PN
    Guillet, P
    Meininger, V
    [J]. LANCET, 1996, 347 (9013) : 1425 - 1431
  • [6] Oral Solubilized Ursodeoxycholic Acid Therapy in Amyotrophic Lateral Sclerosis: A Randomized Cross-Over Trial
    Min, Ju-Hong
    Hong, Yoon-Ho
    Sung, Jung-Joon
    Kim, Sung-Min
    Lee, Jung Bok
    Lee, Kwang-Woo
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2012, 27 (02) : 200 - 206
  • [7] Dexpramipexole effects on functional decline and survival in subjects with amyotrophic lateral sclerosis in a Phase II study: Subgroup analysis of demographic and clinical characteristics
    Rudnicki, Stacy A.
    Berry, James D.
    Ingersoll, Evan
    Archibald, Don
    Cudkowicz, Merit E.
    Kerr, Douglas A.
    Dong, Yingwen
    [J]. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2013, 14 (01) : 44 - 51
1